Tanimoto Mitsune | First Department Of Internal Medicine Nagoya University School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
Human T cell leukemia virus type-1 Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-kB pathway
Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter
Successful Treatment of Limited Disease-Small Cell Lung Cancer with Multimodality Treatment Consisting of Concurrent Chemoradiotherapy, High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation and Surgical Resection
Dock2 participates in bone marrow lympho-hematopoiesis
Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
Glanzmann Thrombasthenia with Acute Myeloid Leukemia Successfully Treated by Bone Marrow Transplantation
Two Novel Gene Mutations in Type I Antithrombin Deficiency
Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
Real-Time Polymerase Chain Reaction for Quantification of HTLV-1 Proviral Load: Application for Analyzing Aberrant Integration of the Proviral DNA in Adult T-Cell Leukemia
Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
Treatment of Refractory Metastatic Choriocarcinoma with Tandem High-Dose Chemotherapy Supported by Peripheral Blood Stem Cell Transplantation : A Case Report
IP-1 Confirmation of the Essential Role of LTB4 in Airway Hyperresponsiveness Using LTA4H-Deficient Mice
Pulmonary infiltration with eosinophilia syndrome complicated with non-Hodgkin's lymphoma of B cell lineage
Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation
Systemic Tumor Embolism Mimicking Gefitinib (‘IRESSA’)-induced Interstitial Lung Disease in a Patient with Lung Cancer
Double High-dose Chemotherapy Supported by Autologous Transplantation of Peripheral Blood Stem Cells for Treatment of an Elderly Patient with Small-Cell Lung Cancer
Metastasis to the Iris in Squamous Cell Lung Cancer
Analysis of 55 Transplantations from Unrelated Volunteer Donors Facilitated by Tokai Marrow Donor Bank
Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
Protein Expression and Constitutive Phosphorylation of Hematopoietic Transcription Factors PU.1 and C/EBPβ in Acute Myeloid Leukemia Blasts
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
Acute myeloid leukemia in the elderly : 159 Nagoya case studies
Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1
Cerebral venous sinus thrombosis after allogeneic stem cell transplantation
Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
Acute Lymphoblastic Leukemia with t(1;9;22)(q32;q34;q11)
Posttransplantation Epstein-Barr Viral Meningitis in a Patient With Chronic Myelogenous Leukemia
De novo Acute Myelogenous Leukemia with Trilineage Myelodysplasia Associated with t(8:21)(q22;q22)
Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
No Significant Association Between HA-1 Incompatibility and Incidence of Acute Graft-Versus-Host Disease After HLA-Identical Sibling Bone Marrow Transplantation in Japanese Patients
CD4- and CD56-positive T-cell line MTA, established from natural killer-like T-cell leukemia/lymphoma
Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
Autoimmune Neutropenia Associated with Multiple Sclerosis
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies

もっと見る

スポンサーリンク